Cargando…
JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924561/ https://www.ncbi.nlm.nih.gov/pubmed/31976485 http://dx.doi.org/10.1097/HS9.0000000000000313 |
_version_ | 1783481747011272704 |
---|---|
author | Govaerts, Inge Jacobs, Kris Vandepoel, Roel Cools, Jan |
author_facet | Govaerts, Inge Jacobs, Kris Vandepoel, Roel Cools, Jan |
author_sort | Govaerts, Inge |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6924561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-69245612020-01-23 JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors Govaerts, Inge Jacobs, Kris Vandepoel, Roel Cools, Jan Hemasphere Letter Wolters Kluwer Health 2019-10-22 /pmc/articles/PMC6924561/ /pubmed/31976485 http://dx.doi.org/10.1097/HS9.0000000000000313 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Letter Govaerts, Inge Jacobs, Kris Vandepoel, Roel Cools, Jan JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors |
title | JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors |
title_full | JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors |
title_fullStr | JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors |
title_full_unstemmed | JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors |
title_short | JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors |
title_sort | jak/stat pathway mutations in t-all, including the stat5b n642h mutation, are sensitive to jak1/jak3 inhibitors |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924561/ https://www.ncbi.nlm.nih.gov/pubmed/31976485 http://dx.doi.org/10.1097/HS9.0000000000000313 |
work_keys_str_mv | AT govaertsinge jakstatpathwaymutationsintallincludingthestat5bn642hmutationaresensitivetojak1jak3inhibitors AT jacobskris jakstatpathwaymutationsintallincludingthestat5bn642hmutationaresensitivetojak1jak3inhibitors AT vandepoelroel jakstatpathwaymutationsintallincludingthestat5bn642hmutationaresensitivetojak1jak3inhibitors AT coolsjan jakstatpathwaymutationsintallincludingthestat5bn642hmutationaresensitivetojak1jak3inhibitors |